CAS Pharmaceutical Medicine
Certificate of Advanced Studies

The Certificate of Advanced Studies (CAS) in Pharmaceutical Medicines program provides specialist knowledge in the field of drug development at an advanced level. The syllabus of the course program covers all aspects of pharmaceutical medicine and drug development as defined by the International Federation of Associations of Pharmaceutical Physicians IFAPP.

This includes the discovery and development of new medicines, clinical trial methodology, good clinical practice and ethics, pharmacovigilance and epidemiology, biostatistics, regulatory affairs, health economics, project management, marketing and new therapeutic approaches.

The CAS program concludes with a multiple choice examination and is worth 20 ECTS.

The ECPM belongs to the Department of Public Health of the Medical Faculty at the University of Basel and is accredited as “Centre of Excellence” by the Innovative Medicines Initiative (IMI) PharmaTrain Executive Board.

All ECPM courses are accredited by IMI PharmaTrain and the International Federation of Associations of Pharmaceutical Physicians (IFAPP) by following the agreed syllabus and quality assurance, and are certified by the University of Basel within the Bologna Title System.

Aufbau / Form

The course program in the amount of 20 ECTS is divided into six modules consisting of four days each over a period of two years. Learning methods comprise online preparation, lectures and group work on case studies. The course language is English.

Zielpublikum / Teilnahmevoraussetzungen

The ECPM Advanced Studies degrees are targeted at representatives from the pharmaceutical industry, service industry, academic and government decision- and policy-makers who already have a good understanding of the basics of drug development and will benefit from a more in-depth, comprehensive and systematic immersion into modern medical product and device development, regulation and market introduction.

In order to enroll for a Certificate of Advanced Studies in Pharmaceutical Medicine, applicants must have a higher university degree, such as a Master’s, MD, PharmD or PhD. Applicants should have a primary interest in medical product discovery, development, regulation and health care system. The program is particularly aimed at professionals who are involved in the drug development process and have already at least one to two years working experience. Applications sur dossier are possible on an individual basis.

Leitung

Dr. Annette Mollet, Managing Director & Head of Training and Education
Prof. Dr. Thomas Szucs, Director

Lehrkörper

The ECPM teaching faculty consists of an international network of about +150 experts from academia, pharmaceutical industry, international organizations (e.g. WHO) and from regulatory authorities (e.g. EMA, FDA and local authorities).

Kontakt

European Center of Pharmaceutical Medicine (ECPM)
Institute of Pharmaceutical Medicine
University of Basel
Nicola Liversidge
Klingelbergstrasse 61
CH-4056 Basel

Phone +41 61 207 19 50
Fax +41 61 207 19 48
ecpm@unibas.ch

Kosten

The tuition fee for the entire course amounts to CHF 14'750.
A reduced fee of CHF 10'500 applies to non-profit organizations.

The tuition fee includes:

Online course material
Lunches and coffee breaks and a welcome aperitif per module
Access to the online media library
Fee for the multiple choice questions (MCQ) exam (Certificate of Advanced Studies)

Not included are the printed course materials, which are provided for CHF 500 and can be ordered optionally.

Zeit

: Next start: August 2025

Website

Further information about the study program can be found on:

European Center of Pharmaceutical Medicine (ECPM)

Trägerschaft

Medical Faculty of the University of Basel

Anmeldung

Register for the Certificate of Advanced Studies in Pharmaceutical Medicine here

Dokumente

Studiengangreglement MAS Medicines Development

Ort

European Center of Pharmaceutical Medicine (ECPM) Institute of Pharmaceutical Medicine University of Basel Klingelbergstrasse 61 CH-4056 Basel

Karte